Medical economics

GSK, Pfizer to merge consumer healthcare units

Pharmaceutical giants GlaxoSmithKline and Pfizer on Wednesday announced a merger of their consumer healthcare units that produce over-the-counter medicines.

Diseases, Conditions, Syndromes

Iran sees highest daily death toll in months as virus surges

Iran's daily coronavirus death toll climbed over 400 for the first time in months on Sunday, as the country, which has long had the region's largest outbreak, battles a post-holiday infection surge.


AstraZeneca in Algeria $125 mn pharmaceuticals deal

British pharmaceuticals giant AstraZeneca plc signed Tuesday a deal with private Algerian firms Salhi and Hasnaoui to build a $125 million (112 million euro) plant in the North African country, the partners announced.


US moves to block Purdue Pharma opioid settlement

The US Justice Department has challenged a plan that would dissolve Purdue Pharma, manufacturer of the OxyContin drug that has been blamed for the country's opioid crisis, while shielding its founders from lawsuits.

Psychology & Psychiatry

Romance: Deal makers and breakers

(HealthDay)—A global study about what men and women want in a mate seems to confirm—to a point—long-established stereotypes.


Pfizer says Hospira purchase will close in early September

Drugmaker Pfizer says it's received the final regulatory approvals for its $15.23 billion purchase of the injectable drug and infusion device maker Hospira, and says the deal will close in early September.

page 1 from 8


Deal may refer to:

This text uses material from Wikipedia, licensed under CC BY-SA